| Target ID: | dt893 |
|---|---|
| CID: | 6445781 |
| Compound Name: | Cp-461 |
| Gene ID: | 1026 |
| Gene Name: | CDKN1A |
| Species: | Homo sapiens (human) |
| PubMed IDs: | 15475462 |
| Action: | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression of CDKN1A protein|(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride promotes the reaction [3,7,11,1 |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt1205 | 91663255 | Sucroferric oxyhydroxide | 1026 | CDKN1A | Bos taurus (cattle) | Ferric oxide, saccharated results in increased expression of CDKN1A protein | Details |
| dt152 | 3339 | Fenofibrate | 1026 | CDKN1A | Rattus norvegicus (Norway rat) | [fenofibrate co-treated with diethylnitrosamine] results in decreased expression of CDKN1A mRNA | Details |
| dt153 | 3339 | Fenofibrate | 1026 | CDKN1A | Rattus norvegicus (Norway rat) | Fenofibrate results in decreased expression of CDKN1A mRNA | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug104 | CP-461 | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||